Anthranilic acid-based diamides derivatives incorporating aryl-isoxazoline pharmacophore as potential anticancer agents: Design, synthesis and biological evaluation

Add time:07/19/2019    Source:sciencedirect.com

A series of novel anthranilic diamides derivatives containing aryl-isoxazoline moiety were designed and synthesized as a part of our ongoing search for potential anticancer agents. Their structures were confirmed by 1H NMR, 13C NMR and ESI-MS analyses. The preliminary assays showed that some of the compounds displayed moderate to good antitumor activities against human lung cancer (NCI-H460), hepatocellular liver carcinoma (HepG2), gastric cancer (SGC-7901 and BGC-823) and breast epithelial adenocarcinoma (MCF-7) cell lines at μM level, which might be developed as novel lead scaffold for potential anticancer agents.

We also recommend Trading Suppliers and Manufacturers of N-(2-CHLOROPHENYL)ANTHRANILIC ACID (cas 10166-39-9). Pls Click Website Link as below: cas 10166-39-9 suppliers

Prev:Affinity and kinetics study of anthranilic acids as HCA2 receptor agonists
Next:X-ray analysis, molecular modeling and NIR-luminescence of erbium(III) 2,4-octanedionate complexes with N,N-donors)